Abstract
The application of nanotechnology to biomedical research is expected to have a major impact leading to the development of new types of diagnostic and therapeutic tools. One focus in nanobiotechnology is to develop safe and efficient drug/gene delivery vehicles. Research into the rational delivery and targeting of pharmaceutical, therapeutic and diagnostic agents is at the forefront of projects in nanomedicine. Silica, as a major and natural component of sand and glass, is a versatile material due to the variety of available chemical and physical modifications that are available, and recently have been widely applied in nanobiotechnology as drug/gene carriers or fluorescent nano-probes. The goal of this brief review is to illustrate selected examples of various functionalized silica nanoparticles as drug/gene delivery systems that have been applied to the arenas of human disease therapy or detection (molecular and cellular imaging).
Keywords: Silica, nanoparticles, drug/gene delivery, nano-probes, targeting, nanotechnology, nanobiotechnology, fluorescein isothiocyanate, sodium cyanide, tetraethoxysilane, thiol-organosilica, electrostatic interaction, plasmid DNA, stereotaxic injections, bromodeoxyuridine, photodynamic drugs, sol-gel, mesoporous channels, proliferation, apoptosis, cytoskeleton, liposomes, perfluorocarbon, luminescent, fluorescent dye, immunosorbent assay, immu-nocytochemistry, immunohistochemistry, DNA microarray, superparamagnetic iron ox-ide, mesenchymal stem cells, polyethylene glycol, glutaraldehyde, Folic acid, adenocarcinoma, pituitary adenoma, antisense oligonucleotides, 2-devinyl-2-(1-hexyloxyethyl) pyropheo-phorbide, mesoporous silica nanoparticles, superparamagnetic iron oxide
Current Cancer Drug Targets
Title: Silica Nanoparticles as Promising Drug/Gene Delivery Carriers and Fluorescent Nano-Probes: Recent Advances
Volume: 11 Issue: 2
Author(s): Y. Liu, C. Lou, H. Yang, M. Shi and H. Miyoshi
Affiliation:
Keywords: Silica, nanoparticles, drug/gene delivery, nano-probes, targeting, nanotechnology, nanobiotechnology, fluorescein isothiocyanate, sodium cyanide, tetraethoxysilane, thiol-organosilica, electrostatic interaction, plasmid DNA, stereotaxic injections, bromodeoxyuridine, photodynamic drugs, sol-gel, mesoporous channels, proliferation, apoptosis, cytoskeleton, liposomes, perfluorocarbon, luminescent, fluorescent dye, immunosorbent assay, immu-nocytochemistry, immunohistochemistry, DNA microarray, superparamagnetic iron ox-ide, mesenchymal stem cells, polyethylene glycol, glutaraldehyde, Folic acid, adenocarcinoma, pituitary adenoma, antisense oligonucleotides, 2-devinyl-2-(1-hexyloxyethyl) pyropheo-phorbide, mesoporous silica nanoparticles, superparamagnetic iron oxide
Abstract: The application of nanotechnology to biomedical research is expected to have a major impact leading to the development of new types of diagnostic and therapeutic tools. One focus in nanobiotechnology is to develop safe and efficient drug/gene delivery vehicles. Research into the rational delivery and targeting of pharmaceutical, therapeutic and diagnostic agents is at the forefront of projects in nanomedicine. Silica, as a major and natural component of sand and glass, is a versatile material due to the variety of available chemical and physical modifications that are available, and recently have been widely applied in nanobiotechnology as drug/gene carriers or fluorescent nano-probes. The goal of this brief review is to illustrate selected examples of various functionalized silica nanoparticles as drug/gene delivery systems that have been applied to the arenas of human disease therapy or detection (molecular and cellular imaging).
Export Options
About this article
Cite this article as:
Liu Y., Lou C., Yang H., Shi M. and Miyoshi H., Silica Nanoparticles as Promising Drug/Gene Delivery Carriers and Fluorescent Nano-Probes: Recent Advances, Current Cancer Drug Targets 2011; 11 (2) . https://dx.doi.org/10.2174/156800911794328411
DOI https://dx.doi.org/10.2174/156800911794328411 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Innovative Cancer Drug Targets: A New Horizon in Oncology
Cancer remains one of the most challenging diseases, with its complexity and adaptability necessitating continuous research efforts into more effective and targeted therapeutic approaches. Recent years have witnessed significant progress in understanding the molecular and genetic basis of cancer, leading to the identification of novel drug targets. These include, but ...read more
Role of Immune and Genotoxic Response Biomarkers in Tumor Microenvironment in Cancer Diagnosis and Treatment
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process of exploring and investigating the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
The Impact of Cancer Neuroscience on Novel Brain Cancer Treatment
Brain cancer remains one of the most challenging malignancies due to its complexity and resistance to conventional therapies. Recent advancements in cancer neuroscience have transformed our understanding of the brain's tumor microenvironment, offering promising insights into novel treatments. By studying the intricate interactions between cancer cells and the nervous system, ...read more
Unraveling the Tumor Microenvironment and Potential Therapeutic Targets: Insights from Single-Cell Sequencing and Spatial Transcriptomics
This special issue will focus on unraveling the complexities of the tumor microenvironment (TME) and identifying key biomarkers for potential therapeutic targets using advanced multi-omics techniques, such as single-cell sequencing and spatial transcriptomics. We seek original research and comprehensive reviews that investigate the heterogeneity and dynamics of the TME, emphasizing ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Potential of Naturally Occurring Lignans as Anticancer
Agents
Current Topics in Medicinal Chemistry Trends in Utilization of the Pharmacological Potential of Chalcones
Current Clinical Pharmacology New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics
Current Topics in Medicinal Chemistry Anti-inflammatory Phytochemicals for Chemoprevention of Colon Cancer
Current Cancer Drug Targets Aspects of the Stability and Bioavailability of Carbohydrates and Carbohydrate Derivatives
Mini-Reviews in Medicinal Chemistry Sentinel Node Imaging
Current Medical Imaging Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem
Current Neuropharmacology Natural Products Targeting Autophagy via the PI3K/Akt/mTOR Pathway as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Himalayan Plants as a Source of Anti-Cancer Agents: A Review
The Natural Products Journal Is Effective and Safe a Radiochemotherapy Approach in Elderly Cancer Patients? A Review
Anti-Cancer Agents in Medicinal Chemistry Anticancer Perspectives on the Fungal-Derived Polyphenolic Hispolon
Anti-Cancer Agents in Medicinal Chemistry Anticancer Effects of Ginsenoside Rh2: A Systematic Review
Current Molecular Pharmacology The Role of Endothelial Dysfunction in Aortic Aneurysms
Current Pharmaceutical Design The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery
Current Cancer Drug Targets Editorial (Thematic Issue: Melanoma Treatment: Finally Some Light at the End of the Tunnel?)
Clinical Cancer Drugs INNO-206 (DOXO-EMCH), an Albumin-Binding Prodrug of Doxorubicin Under Development for Phase II Studies
Current Bioactive Compounds Targeted Delivery of Anti-Inflammatory Agents to Tumors
Current Pharmaceutical Design The Emergence of Immune-checkpoint Inhibitors in Colorectal Cancer Therapy
Current Drug Targets Risk Factors for Myocardial Infarction in Women and Men: A Review of the Current Literature
Current Pharmaceutical Design Recent Developments in the Synthesis and Applications of C5-Substituted Pyrimidine Nucleosides and Nucleotides
Current Organic Chemistry